Barclays »

Tenax Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Tenax Therapeutics (TENX) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Tenax Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tenax Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tenax Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-03-31 $267k 17k 15.99
2025-06-30 $0 11 0.00

More positions owned by Barclays

Ishares Tr Opt Put Option (EEM)
Microsoft Corporation (MSFT)
STATE STR SPDR S&ampP 500 ETF T Opt Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Opt Call Option (QQQ)
Ishares Tr Fund (IWM)
Apple (AAPL)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Ishares Tr Opt Put Option (HYG)
JPMORGAN CHASE &amp Opt Call Option (JPM)
Alphabet Inc Class C cs (GOOG)

View all positions for Barclays

Top funds holding Tenax Therapeutics

Henderson Group
VR Adviser
Perceptive Advisors
Ikarian Capital
Stonepine Capital Management
Logos Global Management
Morgan Stanley
Velan Capital Investment Management
Adage Capital Partners GP
Point72 Asset Management
Millennium Management
Armistice Capital
Siren
Boothbay Fund Management
TD Asset Management

View all funds holding Tenax Therapeutics